-+ 0.00%
-+ 0.00%
-+ 0.00%

Merck’s M Ventures joins Remepy’s $36 million Series A round led by O.G. Venture Partners

PUBT·08/13/2026 07:49:00
Listen to the news
Merck’s M Ventures joins Remepy’s $36 million Series A round led by O.G. Venture Partners
  • Remepy raised USD 36 million in a Series A led by O.G. Venture Partners, with participation from Merck Ventures BV.
  • New York-based Remepy develops “Hybrid Drugs” that combine prescription medicines with personalized, AI-driven therapeutic apps.
  • Proceeds earmarked for pharmaceutical co-development partnerships, pipeline expansion, and a global Phase III trial of Parkinson’s program Hybridopa starting Q4 2026.
  • Financing lifted total capital raised to USD 62 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck Ventures BV published the original content used to generate this news brief on August 12, 2026, and is solely responsible for the information contained therein.